U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07943832) titled 'Blended Eclectic Programme to Improve Community Preparedness for Acute Myocardial Infarction' on Nov. 09.
Brief Summary: Coronary artery disease (CAD) is the leading cause of death and disability worldwide, and acute myocardial infarction (AMI, commonly known as heart attack) is its most severe and life-threatening form. In a heart attack, the time from symptoms onset to the receipt of reperfusion therapy to restore blood flow ("total ischaemic time") strongly influences how much heart muscle is saved and whether the patient survives. The longer the delay, the worse the outcome.
Despite effort to reduce in-hospital delay through es...